Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

BAT Gains on Boost From E-Cigarettes, Oral Nicotine

Published 02/11/2022, 05:13 AM
Updated 02/11/2022, 05:14 AM
© Reuters.

By Dhirendra Tripathi

Investing.com – ADRs of British American Tobacco (NYSE:BTI) traded 0.4% higher Friday as sales of e-cigarettes, heated tobacco and nicotine grew in 2021, underpinning the company’s focus on growing new categories of business.

Compounding the gains in the stock was a new 2-billion-pound ($2.72 billion) share repurchase program and a 1% rise in the dividend to 218 pence.

Revenue from new categories climbed 51% to 2.05 billion pounds. For the first time, the segment reported a narrower loss, reducing the drag on group earnings growth. BAT said the unit is on track to break even and deliver revenue of 5 billion pounds by 2025.

The company was able to take its non-combustible products such as Vuse e-cigarettes, glo heated tobacco and Velo oral nicotine to 4.8 million more consumers in 2021, capping a year in which pressure from funds, activists and ESG-focused organizations only increased. Over 18 million people now use those products and BAT aims to accelerate the shift to them by increasing investment in the space.

Total revenue in the year rose 7% to near 26 billion pounds.

BAT (LON:BATS) expects revenue growth of 3%-5% this year, and around 9% growth in adjusted EPS. That's despite the long-term structural demand decline for tobacco globally.

Adjusted diluted earnings per share in 2021 were 329 pence.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.